REQUEST A DEMO
Total
USD $0.00
Search more companies

Rc2 Pharmaceutical S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Household Appliance Stores | All Other Professional, Scientific, and Technical Services
Full name: Rc2 Pharmaceutical S.A.S. Profile Updated: September 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Rc2 Pharmaceutical S.A.S. is a company in Colombia, with a head office in Envigado. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Rc2 Pharmaceutical S.A.S. was incorporated on September 04, 2023. It currently has a total number of 4 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 277.96% in 2024. Over the same period, its total assets grew by 118.2%. In 2024, Rc2 Pharmaceutical S.A.S.’s net profit margin increased by 14.87%.

Headquarters
Dg 32 D 31 Sur 54
Envigado; Antioquia;

Contact Details: Purchase the Rc2 Pharmaceutical S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Rc2 Pharmaceutical S.A.S. report to view the information.
Financial Auditors:
Purchase the Rc2 Pharmaceutical S.A.S. report to view the information.
Incorporation Date:
September 04, 2023
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Rc2 Pharmaceutical S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
277.96%
Total operating revenue
277.96%
EBITDA
833.87%
Net Profit (Loss) for the Period
939.63%
Total assets
118.2%
Total equity
44.53%
Net Profit Margin
14.87%
Return on Equity (ROE)
25.35%
Quick Ratio
-208.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?